Company Filing History:
Years Active: 2024
Title: Magali Muller: Innovator in Modified TNF-α Antibodies
Introduction
Magali Muller is a prominent inventor based in Pulversheim, France. She has made significant contributions to the field of biotechnology, particularly in the development of modified TNF-α antibodies. Her work focuses on innovative treatments for inflammatory disorders, showcasing her dedication to advancing medical science.
Latest Patents
Magali Muller holds 1 patent for her invention titled "Modified TNF-α antibodies and uses thereof." This patent relates to modified anti-TNFα polypeptides, compositions that include these polypeptides, methods for their production, and their application in treating various diseases. Specifically, her research emphasizes the treatment of inflammatory disorders using these modified polypeptides, highlighting their potential therapeutic benefits.
Career Highlights
Magali Muller is associated with Bright Peak Therapeutics AG, where she continues to push the boundaries of scientific research. Her work is instrumental in developing new therapeutic strategies that can improve patient outcomes in inflammatory conditions.
Collaborations
Magali collaborates with esteemed colleagues such as Bertolt Kreft and Vijaya Raghavan Pattabiraman. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.
Conclusion
Magali Muller exemplifies the spirit of innovation in biotechnology through her work on modified TNF-α antibodies. Her contributions are paving the way for new treatments that could significantly impact the management of inflammatory disorders.